A Double-Blind Placebo-Controlled Study of Omega-3 Fatty Acids in Children and Adolescents With Tourette's Disorder

被引：0
|
作者：
Gabbay, Vilma [1 ]
Coffey, Barbara [1 ]
Alonso, Carmen [1 ]
Guttman, Leah [1 ]
Gottlieb, Lev [1 ]
Hirsch, Glenn [1 ]
机构：
[1] NYU, Ctr Child Study, New York, NY 10003 USA
来源：
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY | 2008年 / 18卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：636 / 636
页数：1
相关论文
共 50 条
  • [41] A randomized, double-blind, placebo-controlled trial of metoclopramide for the treatment of Tourette's disorder
    Nicolson, R
    Craven-Thuss, B
    Smith, J
    McKinlay, BD
    Castellanos, FX
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2005, 44 (07): : 640 - 646
  • [42] A double-blind placebo-controlled randomised trial of omega-3 supplementation in children with moderate ADHD symptoms
    Catherine Cornu
    Catherine Mercier
    Tiphanie Ginhoux
    Sandrine Masson
    Julie Mouchet
    Patrice Nony
    Behrouz Kassai
    Valérie Laudy
    Patrick Berquin
    Nathalie Franc
    Marie-France Le Heuzey
    Hugues Desombre
    Olivier Revol
    European Child & Adolescent Psychiatry, 2018, 27 : 377 - 384
  • [43] Omega-3 fatty acids does not affect physical activity and body weight in primary school children – a double-blind randomized placebo-controlled trial
    V. Svensson
    E. Johansson
    M. Fischer
    S. L. Deng
    M. Hagströmer
    P. Danielsson
    Scientific Reports, 8
  • [44] Omega-3 fatty acids does not affect physical activity and body weight in primary school children - a double-blind randomized placebo-controlled trial
    Svensson, V.
    Johansson, E.
    Fischer, M.
    Deng, S. L.
    Hagstromer, M.
    Danielsson, P.
    SCIENTIFIC REPORTS, 2018, 8
  • [45] Failure of omega-3 polyunsaturated fatty acids in prevention of migraine: a double-blind study versus placebo
    Pradalier, A
    Bakouche, P
    Baudesson, G
    Delage, A
    Cornaille-Lafage, G
    Launay, JM
    Biason, P
    CEPHALALGIA, 2001, 21 (08) : 818 - 822
  • [46] A double-blind placebo-controlled study of lithium in hospitalized aggressive children and adolescents with conduct disorder
    Malone, RP
    Delaney, MA
    Luebbert, JF
    Cater, J
    Campbell, M
    ARCHIVES OF GENERAL PSYCHIATRY, 2000, 57 (07) : 649 - 654
  • [47] Randomized, Double-Blind, Placebo-Controlled Trial Demonstrates the Efficacy and Safety of Oral Aripiprazole for the Treatment of Tourette's Disorder in Children and Adolescents
    Sallee, Floyd
    Kohegyi, Eva
    Zhao, Joan
    McQuade, Robert
    Cox, Kevin
    Sanchez, Raymond
    van Beek, Alet
    Nyilas, Margaretta
    Carson, William
    Kurlan, Roger
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2017, 27 (09) : 771 - 781
  • [48] Fatty acids in ADHD: plasma profiles in a placebo-controlled study of Omega 3/6 fatty acids in children and adolescents
    Johnson, Mats
    Mansson, Jan-Eric
    Ostlund, Sven
    Fransson, Gunnar
    Areskoug, Bjorn
    Hjalmarsson, Kerstin
    Landgren, Magnus
    Kadesjo, Bjorn
    Gillberg, Christopher
    ADHD-ATTENTION DEFICIT AND HYPERACTIVITY DISORDERS, 2012, 4 (04) : 199 - 204
  • [49] A pilot randomized, placebo-controlled, double-blind study of omega-3 fatty acids to prevent paclitaxel-associated acute pain syndrome.
    Dayao, Zoneddy R.
    Brown-Glaberman, Ursa Abigail
    Pankratz, V. Shane
    Chen, Lu
    Lafky, Jacqueline M.
    Loprinzi, Charles L.
    Barton, Debra L.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [50] A randomised double-blind placebo-controlled trial of minocycline and/or omega-3 fatty acids added to treatment as usual for at risk Mental States: The NAYAB study
    Qurashi, Inti
    Chaudhry, Imran B.
    Khoso, Ameer B.
    Husain, Muhammad Omair
    Hafeez, Danish
    Kiran, Tayyeba
    Lane, Steven
    Naqvi, Haider A.
    Minhas, Fareed A.
    Nizami, Asad Tamizuddin
    Razzaque, Bushra
    Bokhari, Sumira Qambar
    Yung, Alison R.
    Deakin, Bill
    Husain, Nusrat
    BRAIN BEHAVIOR AND IMMUNITY, 2024, 115 : 609 - 616
12345